Melinta Therapeutics’ Post

READ! This is why AAKP is working with transplant patients, donors/families, Congress, media, and allies American Society of Transplantation, American Society of Transplant Surgeons, and Share the Gift to REVERSE the CMS decision restricting transplant surveillance blood tests. HEY, CMS - PATIENTS FIRST! https://bit.ly/3v64uxk #AAKPforPatients

The first successful human organ transplant was a kidney transplant performed on December 23, 1954, by Dr. Joseph Murray and his team at Peter Bent Brigham Hospital in Boston. The groundbreaking surgery was conducted between identical twins, Ronald and Richard Herrick, to eliminate the issue of organ rejection. Ronald donated one of his kidneys to his brother Richard, who was suffering from chronic kidney failure. The success of this operation marked a major milestone in medical history, paving the way for modern organ transplantation. Dr. Murray's innovative work in transplantation earned him the Nobel Prize in Physiology or Medicine in 1990. This successful transplant not only saved Richard Herrick's life but also opened the door to the development of immunosuppressive drugs, allowing transplants between non-identical individuals. Source: National Kidney Foundation #MedicalHistory #HealthcareInnovation #OrganTransplant #KidneyTransplant #MedicalBreakthrough #HealthTrivia #MedicalMilestone #NobelPrize #SurgicalAdvancements #HealthcareHeroes

Progress in Regenerative Procedures for Pain Dr. Ricardo Ruiz-Lopez gives a detailed presentation on the advancements in regenerative procedures for pain management, highlighting the importance of innovation in pain medicine. He defines regenerative medicine and compares adipose tissue derived and bone marrow derived stem cells. He discusses the lack of clinical evidence for regenerative therapies. Dr. Ruiz-Lopez discusses the findings of human trials involving the use of platelet-rich plasma (PRP) in intervertebral discs as a promising therapeutic option. Finally, he identifies key areas of research and innovation in spine surgery and annular repair. Watch the full lecture at: https://lnkd.in/g4v9NSHB Join PainCast Pro for unlimited access to exclusive videos and lectures from leading physicians. Get started now! https://paincast.com/pro/ #regenerative #medicine #regenerative #procedures #painmanagement #innovation #pain #adipose #tissue #derived #stem #cells #bone #marrow #derived #stemcells

🌟 Another publication Alert ! 🌟 Thrilled to share that our case report titled "Microwave Ablation for Osteoid Osteoma in a Young Patient: A Case Report" has been published in Cureus Journal of Medical Science ! This study highlights the innovative use of microwave ablation in treating osteoid osteoma, showcasing promising results for young patients. This is a significant step forward in advancing minimally invasive treatments in orthopedic oncology. Co author: Elijah Skarlus Doelakeh Read the full article here: https://lnkd.in/gGJRuMuZ Researchgate: https://lnkd.in/gB5DYtvk #MedicalResearch #OrthopedicOncology #MicrowaveAblation #OsteoidOsteoma #HealthcareInnovation #PublishedResearch

The CRYPTICS Trial (NCT04709705) is enrolling patients undergoing complex cardiac surgery who develop bleeding requiring platelet transfusion. The study compares the effectiveness of cryopreserved platelets to that of liquid stored platelets. Today, we are thrilled to announce that enrollment in Cellphire’s Phase 2/3 Clinical Trial of Cryopreserved Platelets (CPP) has accelerated and is more than halfway towards Interim Analysis! Special kudos goes to our top enrolling sites! Dr. John Spratt and Team at University of Florida- Gainesville Dr. Hamza Aziz and Team at Johns Hopkins University Dr. Joseph DeSimone and Team at Dartmouth-Hitchcock Medical Center Dr. Robert Kramer and Team at Maine Medical Center Cellphire’s Vision: We will save lives by creating transformative, stabilized cellular therapeutics. #Cardiopulmonarybypass #platelets #enrollment #CRYPTICS #hemostasis #Cellphire #biotech #clinicaltrials

In honor of #WorldCancerDay, we’re thanking the site admins, data submitters, hospital leaders, #PROMS site administrators, orthopaedic surgeons and others who participate in the AAOS Musculoskeletal #Tumor Registry. Your support of the #MsTR fuels #cancer research, treatment advancements and survivor stories. Together, we can start to have a better understanding of Sarcomas. Learn how you can participate in #OrthoRegistries: https://bit.ly/3HL3lyj

Do you have an injury that’s keeping you from being active? We may have an innovative, non-surgical treatment solution for you! Orthobiologics, including PRP and Stem Cell therapies, may help avoid or delay surgical intervention as well as be an adjunct to help improve surgical outcomes. We treat patients of all ages, ranging from high school athletes to older adults. Our very own Dr. David Hergan, joint replacement and sports medicine surgeon at Middlesex Orthopedic & Spine Associates, answers frequently asked questions about orthobiologics and regenerative medicine in this Q&A. Learn more about regenerative medicine here: https://ow.ly/FVqC50QZ4qw

You have choices when it comes to tumor localization. Explore replacing tumor localization with Surgical Marker Navigation. Visit Sirius Medical #ASBrS24, Booth 117. The American Society of Breast Surgeons, TME Breast Care Network, Learn Look Locate, #breastcancerawareness, #Pintuition, #innovation

Don’t miss the opportunity to meet our CEO, Juliane Bernholz, PhD, at the 8th edition of the Kidney Disease Clinical Trialists Workshop in Washington, DC, from March 15-16. As a speaker, she will give an industry view of clinical trials in kidney disease and discuss the current Phase 2 study of ilofotase alfa for the preventative treatment of cardiac surgery-associated renal damage.   #KDCT #kidneydisease

In a recent MD Anderson Cancer Center study analyzing re-excision rates in breast-conserving surgery and associated healthcare costs, "Reoperations were associated with 24% higher costs in both the commercial and Medicare cohorts, which translated into $21,607 and $8559 incremental costs, respectively." Read the study and learn how reoperations in #breastcancer care contribute to increased financial burden on the healthcare system. https://lnkd.in/e4Cj88GT